Pfizer stock was falling Friday after the biopharmaceutical company announced that it will not be moving forward with a Phase 3 trial of its weight loss candidate.
Continue reading this article with a Barron’s subscription.
Source: finance.yahoo.com
Related posts:
Facebook Stock Is Rising. Today’s the Day It Might End Its Slide.
Big Changes to 401(k) Retirement Plans Get Closer With Senate Vote
Boeing stock leads the Dow's decliners after reports of 757 jet breaking in half
Jeff Bezos Backed Real Estate Investment Platform Fully Funds Six Properties In Under 12 Hours
The Riskiest Bets in the Stock Market Are the Most Popular